More on the Beckwith-Wiedemann syndrome Sir, We read with interest the article on Beckwith-Wiedemann syndrome: a quantitative, immunohistochemical study of pancreatic islet cell populations by Stefan et al. [1] .
Vitamin D deficiency and the endocrine pancreas
Sir, Gedik and Akalin [1] have demonstrated that insulin release following glucose challenge is impaired in patients with vitamin-D deficiency, and that it is restored to normal following vitamin-D treatment. This phenomenon is well established [2] , but it is not established that vitamin D deficiency has no effect on glucagon release.
There are a few unusual features about the patients studied by Gedik and Akalin [1] which should be highlighted. All of their vitamin-D deficient patients had plasma calcium concentrations in the normal range. This can occur in vitamin-D deficiency, but is usually associated with secondary hyperparathyroidism. Parathyroid hormone (PTH) concentrations in sera of these patients were not elevated. This is particularly surprising since the patients had severe vitamin-D deficiency according to clinical and radiological criteria. Furthermore, PTH concentrations did not alter following treatment; this is most unusual. We have previously described the persistence of PTH hypersecretion following vitamin D therapy in osteomalacia, but even in this select group of patients there was some fall in PTH [1] . We have recently demonstrated a significant inverse correlation between 1,25dihydroxyvitaminD [1,25(OH)zD] and PTH concentrations (Fig. 1) in patients with vitamin D deficiency [4] . It is surprising, therefore, not to find elevated PTH concentrations in association with the low concentrations of 1,25(OH)2D described. It is also relevant to mention that we have shown a significant inverse relationship between bone density and PTH concentrations in patients with vita- 
